Ebola in DR Congo: Deadliest Outbreak Yet

Sun Sep 06 2026 04:39:39 GMT+0000 (Coordinated Universal Time)

Ebola outbreak in DR Congo peaks with record 2,300 deaths, outpacing previous epidemic. Experts emphasize rapid vaccination and case containment.

The Democratic Republic of Congo’s latest Ebola outbreak has become the deadliest ever, with more than 2,300 confirmed deaths. The virus, a rare Bundibugyo strain, spreads rapidly across six provinces, killing a person every 30 minutes. No approved vaccine exists yet, though researchers are testing candidates inspired by the AstraZeneca coronavirus technology. The World Health Organization aims to curb transmission within three months, reinforcing the need for strengthened surveillance and community outreach.

Ebola in DR Congo: Deadliest Outbreak Yet

Medical staff inaugurating a new Ebola treatment centre in Rwakole, Bunia, DR Congo.

The current outbreak has eclipsed all previous Ebola cases in the country. Official counts now exceed 2,325 deaths since the outbreak was declared on 15 May.

The outbreak is rapidly spreading across six of the 26 provinces, with a death occurring roughly every 30 minutes, according to UN humanitarian chief Tom Fletcher. The virus, a rare Bundibugyo species, has no licensed vaccine, but several candidates—one based on Oxford-AstraZeneca technology—are under development.

Health authorities report 4,945 confirmed cases, including 101 new cases in the last 24 hours. Outside the Congo, only 20 cases have been confirmed in neighbouring Uganda, two in Germany, and one in France.

The World Health Organization aims to bring transmission under control in three months, recognising that this is not a 'complete elimination' but a significant slowdown in spread.

Key symptoms—fever, headache, fatigue, vomiting, and diarrhoea—are similar to flu or malaria, making early diagnosis challenging. The virus spreads via direct contact with bodily fluids such as blood, vomit, or urine. Vigilance and early isolation remain critical.

In the UK, the MHRA has authorised first‑human trials for a vaccine targeting Bundibugyo. The University of Oxford team is extending its coronavirus vaccine platform to this new Ebola strain.

WHO’s clinical trial will also assess two existing antiviral therapies for effectiveness in DRM Congo contexts, offering hope for improved survival rates.

Public health challenges arise from years of conflict and an ever‑moving population, complicating outbreak control efforts. Enhanced surveillance, community engagement, and rapid response teams are crucial to stem further mortality.